Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor

Lisa M Rimsza, Karen Pastos, Kenneth Massey, Raul Braylan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Lymph nodes (LN) involved with small lymphocytic lymphoma (SLL) reportedly contain increased numbers of microvessels that may constitute a therapeutic target in this disease. We investigated the secretion of the angiogenic growth factor, basic fibroblastic growth factor (bFGF), from primary tissue cultures of 15 LN with SLL and 10 reactive LN. bFGF was detected from the resulting conditioned media (CM) in 13/15 SLL samples (mean 92 ± 30, range 5-420 pg/ml) but was undetectable in CM from all reactive lymph nodes. CM was also used in a 72-h human umbilical vein endothelial cell (HUVEC) proliferation assay. HUVEC proliferation increased in the presence of SLL CM (70 ± 17%, range -4-194%), proportional to secreted levels of bFGF (R2 = 0.95), and was reversed by depleting bFGF from CM. Previous SLL studies have examined either patient serum samples or paraffin-embedded lymph node tissue sections. This is the first study to examine the secretion of an angiogenic growth factor from primary cultures of lymph node cells. Our results indicate that bFGF is probably the primary mediator responsible for increased angiogenesis in involved nodes. These findings may be pertinent to future investigation into the mechanisms of increased angiogenesis in SLL.

Original languageEnglish (US)
Pages (from-to)753-758
Number of pages6
JournalBritish Journal of Haematology
Volume120
Issue number5
DOIs
StatePublished - Mar 1 2003

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Intercellular Signaling Peptides and Proteins
Conditioned Culture Medium
Lymph Nodes
Angiogenesis Inducing Agents
Human Umbilical Vein Endothelial Cells
Cell Proliferation
Microvessels
Paraffin
Serum

Keywords

  • Angiogenesis
  • bFGF
  • Endothelium
  • SLL

ASJC Scopus subject areas

  • Hematology

Cite this

Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor. / Rimsza, Lisa M; Pastos, Karen; Massey, Kenneth; Braylan, Raul.

In: British Journal of Haematology, Vol. 120, No. 5, 01.03.2003, p. 753-758.

Research output: Contribution to journalArticle

@article{76b5fb758be74c8a8920f545d88fb065,
title = "Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor",
abstract = "Lymph nodes (LN) involved with small lymphocytic lymphoma (SLL) reportedly contain increased numbers of microvessels that may constitute a therapeutic target in this disease. We investigated the secretion of the angiogenic growth factor, basic fibroblastic growth factor (bFGF), from primary tissue cultures of 15 LN with SLL and 10 reactive LN. bFGF was detected from the resulting conditioned media (CM) in 13/15 SLL samples (mean 92 ± 30, range 5-420 pg/ml) but was undetectable in CM from all reactive lymph nodes. CM was also used in a 72-h human umbilical vein endothelial cell (HUVEC) proliferation assay. HUVEC proliferation increased in the presence of SLL CM (70 ± 17{\%}, range -4-194{\%}), proportional to secreted levels of bFGF (R2 = 0.95), and was reversed by depleting bFGF from CM. Previous SLL studies have examined either patient serum samples or paraffin-embedded lymph node tissue sections. This is the first study to examine the secretion of an angiogenic growth factor from primary cultures of lymph node cells. Our results indicate that bFGF is probably the primary mediator responsible for increased angiogenesis in involved nodes. These findings may be pertinent to future investigation into the mechanisms of increased angiogenesis in SLL.",
keywords = "Angiogenesis, bFGF, Endothelium, SLL",
author = "Rimsza, {Lisa M} and Karen Pastos and Kenneth Massey and Raul Braylan",
year = "2003",
month = "3",
day = "1",
doi = "10.1046/j.1365-2141.2003.04145.x",
language = "English (US)",
volume = "120",
pages = "753--758",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor

AU - Rimsza, Lisa M

AU - Pastos, Karen

AU - Massey, Kenneth

AU - Braylan, Raul

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Lymph nodes (LN) involved with small lymphocytic lymphoma (SLL) reportedly contain increased numbers of microvessels that may constitute a therapeutic target in this disease. We investigated the secretion of the angiogenic growth factor, basic fibroblastic growth factor (bFGF), from primary tissue cultures of 15 LN with SLL and 10 reactive LN. bFGF was detected from the resulting conditioned media (CM) in 13/15 SLL samples (mean 92 ± 30, range 5-420 pg/ml) but was undetectable in CM from all reactive lymph nodes. CM was also used in a 72-h human umbilical vein endothelial cell (HUVEC) proliferation assay. HUVEC proliferation increased in the presence of SLL CM (70 ± 17%, range -4-194%), proportional to secreted levels of bFGF (R2 = 0.95), and was reversed by depleting bFGF from CM. Previous SLL studies have examined either patient serum samples or paraffin-embedded lymph node tissue sections. This is the first study to examine the secretion of an angiogenic growth factor from primary cultures of lymph node cells. Our results indicate that bFGF is probably the primary mediator responsible for increased angiogenesis in involved nodes. These findings may be pertinent to future investigation into the mechanisms of increased angiogenesis in SLL.

AB - Lymph nodes (LN) involved with small lymphocytic lymphoma (SLL) reportedly contain increased numbers of microvessels that may constitute a therapeutic target in this disease. We investigated the secretion of the angiogenic growth factor, basic fibroblastic growth factor (bFGF), from primary tissue cultures of 15 LN with SLL and 10 reactive LN. bFGF was detected from the resulting conditioned media (CM) in 13/15 SLL samples (mean 92 ± 30, range 5-420 pg/ml) but was undetectable in CM from all reactive lymph nodes. CM was also used in a 72-h human umbilical vein endothelial cell (HUVEC) proliferation assay. HUVEC proliferation increased in the presence of SLL CM (70 ± 17%, range -4-194%), proportional to secreted levels of bFGF (R2 = 0.95), and was reversed by depleting bFGF from CM. Previous SLL studies have examined either patient serum samples or paraffin-embedded lymph node tissue sections. This is the first study to examine the secretion of an angiogenic growth factor from primary cultures of lymph node cells. Our results indicate that bFGF is probably the primary mediator responsible for increased angiogenesis in involved nodes. These findings may be pertinent to future investigation into the mechanisms of increased angiogenesis in SLL.

KW - Angiogenesis

KW - bFGF

KW - Endothelium

KW - SLL

UR - http://www.scopus.com/inward/record.url?scp=0037337060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037337060&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2003.04145.x

DO - 10.1046/j.1365-2141.2003.04145.x

M3 - Article

VL - 120

SP - 753

EP - 758

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -